Matches in SemOpenAlex for { <https://semopenalex.org/work/W2135485978> ?p ?o ?g. }
Showing items 1 to 98 of
98
with 100 items per page.
- W2135485978 endingPage "1154" @default.
- W2135485978 startingPage "1149" @default.
- W2135485978 abstract "The analysis of weakly basic drugs such as salmeterol xinafoate (SX) by reverse-phase liquid chromatography remains a problem, particularly when present in combination with other drugs such as steroids and weak acids. This study describes the validation of an assay for a weakly basic drug, salmeterol (SB), its weakly acidic counter-ion, 1-hydroxy-2-naphthoic acid (XA), and the neutral glucocorticoid, fluticasone propionate (FP) using a second-generation silica stationary phase (Inertsil ODS-2). The assay utilized an Inertsil ODS-2 base-deactivated 250 mm x 4.6mm, 5 microm HPLC column, with 75:25 methanol:0.6% aqueous ammonium acetate as the mobile phase. Under these near neutral conditions, SB demonstrated a good peak shape (tailing factor=1.21+/-0.02, n=85). The method provided a short analysis time: XA, t(R)=2.96 min; SB, t(R)=5.23 min and FP, t(R)=7.01 min. The assay displayed good sensitivity for both XA (LOD for SX=0.22 microgmL(-1)) and SB (LOD for SX=0.26 microgmL(-1)). The limit of detection for FP was 0.19 microgmL(-1). Neither of the drugs was found to interfere in the determination of the other and the assay accuracy (% recovery) was high (the recoveries were: 99.58+/-1.85% for XA, 99.49+/-1.88% for SB and 100.24+/-1.28% for FP). The assay reproducibility was determined with a mean coefficient of variance for the five calibration concentrations of XA=0.71+/-0.18%; SB=1.11+/-0.64% and FP=0.92+/-0.14%. Analysis of a pressurized metered dose inhaler formulation demonstrated recovery of the analytes that are within pharmacopoeial limits. It was shown that RP-HPLC was suitable for the high throughput analysis of the combination of SX and FP." @default.
- W2135485978 created "2016-06-24" @default.
- W2135485978 creator A5031953390 @default.
- W2135485978 creator A5034430324 @default.
- W2135485978 creator A5053170726 @default.
- W2135485978 date "2006-03-01" @default.
- W2135485978 modified "2023-10-16" @default.
- W2135485978 title "Validation of a reverse-phase high performance liquid chromatographic method for concurrent assay of a weak base (salmeterol xinafoate) and a pharmacologically active steroid (fluticasone propionate)" @default.
- W2135485978 cites W1565827078 @default.
- W2135485978 cites W1965735640 @default.
- W2135485978 cites W1995508048 @default.
- W2135485978 cites W1998770316 @default.
- W2135485978 cites W2007263467 @default.
- W2135485978 cites W2011266592 @default.
- W2135485978 cites W2013930428 @default.
- W2135485978 cites W2030537658 @default.
- W2135485978 cites W2036498002 @default.
- W2135485978 cites W2042789260 @default.
- W2135485978 cites W2044251046 @default.
- W2135485978 cites W2062949406 @default.
- W2135485978 cites W2065458102 @default.
- W2135485978 cites W2089362621 @default.
- W2135485978 cites W2101259402 @default.
- W2135485978 cites W2315055332 @default.
- W2135485978 doi "https://doi.org/10.1016/j.jpba.2005.09.028" @default.
- W2135485978 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16280225" @default.
- W2135485978 hasPublicationYear "2006" @default.
- W2135485978 type Work @default.
- W2135485978 sameAs 2135485978 @default.
- W2135485978 citedByCount "51" @default.
- W2135485978 countsByYear W21354859782012 @default.
- W2135485978 countsByYear W21354859782013 @default.
- W2135485978 countsByYear W21354859782014 @default.
- W2135485978 countsByYear W21354859782015 @default.
- W2135485978 countsByYear W21354859782016 @default.
- W2135485978 countsByYear W21354859782017 @default.
- W2135485978 countsByYear W21354859782018 @default.
- W2135485978 countsByYear W21354859782019 @default.
- W2135485978 countsByYear W21354859782020 @default.
- W2135485978 countsByYear W21354859782021 @default.
- W2135485978 countsByYear W21354859782022 @default.
- W2135485978 countsByYear W21354859782023 @default.
- W2135485978 crossrefType "journal-article" @default.
- W2135485978 hasAuthorship W2135485978A5031953390 @default.
- W2135485978 hasAuthorship W2135485978A5034430324 @default.
- W2135485978 hasAuthorship W2135485978A5053170726 @default.
- W2135485978 hasConcept C119128265 @default.
- W2135485978 hasConcept C126322002 @default.
- W2135485978 hasConcept C141071460 @default.
- W2135485978 hasConcept C179998833 @default.
- W2135485978 hasConcept C185592680 @default.
- W2135485978 hasConcept C2776042228 @default.
- W2135485978 hasConcept C2776719499 @default.
- W2135485978 hasConcept C2776804153 @default.
- W2135485978 hasConcept C2779028295 @default.
- W2135485978 hasConcept C2780014933 @default.
- W2135485978 hasConcept C2780782300 @default.
- W2135485978 hasConcept C43617362 @default.
- W2135485978 hasConcept C55493867 @default.
- W2135485978 hasConcept C71924100 @default.
- W2135485978 hasConcept C9893847 @default.
- W2135485978 hasConceptScore W2135485978C119128265 @default.
- W2135485978 hasConceptScore W2135485978C126322002 @default.
- W2135485978 hasConceptScore W2135485978C141071460 @default.
- W2135485978 hasConceptScore W2135485978C179998833 @default.
- W2135485978 hasConceptScore W2135485978C185592680 @default.
- W2135485978 hasConceptScore W2135485978C2776042228 @default.
- W2135485978 hasConceptScore W2135485978C2776719499 @default.
- W2135485978 hasConceptScore W2135485978C2776804153 @default.
- W2135485978 hasConceptScore W2135485978C2779028295 @default.
- W2135485978 hasConceptScore W2135485978C2780014933 @default.
- W2135485978 hasConceptScore W2135485978C2780782300 @default.
- W2135485978 hasConceptScore W2135485978C43617362 @default.
- W2135485978 hasConceptScore W2135485978C55493867 @default.
- W2135485978 hasConceptScore W2135485978C71924100 @default.
- W2135485978 hasConceptScore W2135485978C9893847 @default.
- W2135485978 hasIssue "5" @default.
- W2135485978 hasLocation W21354859781 @default.
- W2135485978 hasLocation W21354859782 @default.
- W2135485978 hasOpenAccess W2135485978 @default.
- W2135485978 hasPrimaryLocation W21354859781 @default.
- W2135485978 hasRelatedWork W1871281899 @default.
- W2135485978 hasRelatedWork W1964259887 @default.
- W2135485978 hasRelatedWork W1998279148 @default.
- W2135485978 hasRelatedWork W2013299392 @default.
- W2135485978 hasRelatedWork W2032191029 @default.
- W2135485978 hasRelatedWork W2053210750 @default.
- W2135485978 hasRelatedWork W2084062459 @default.
- W2135485978 hasRelatedWork W2135485978 @default.
- W2135485978 hasRelatedWork W2155596957 @default.
- W2135485978 hasRelatedWork W2382339615 @default.
- W2135485978 hasVolume "40" @default.
- W2135485978 isParatext "false" @default.
- W2135485978 isRetracted "false" @default.
- W2135485978 magId "2135485978" @default.
- W2135485978 workType "article" @default.